R&D of Biomaterials

A firm that secures competitiveness through continuous development of
materials and the nurturing of bio specialists

ARisT Platform

HnB9 hopes to make a successful entry into the market by commercializing peptidomimetic materials, compound materials, drugs based on Drug Repositioning, medical equipment, cosmetics, and more that are developed using
the ARisT (Advanced Remodeling in silico Technology) Platform, the most advanced computer simulation and remodeling technology in Korea.